Enable fast, accurate identification and susceptibility results from positive blood cultures
Have you realized? The ability to appropriately treat bloodstream infections (BSIs) and sepsis relies largely on the quality of your sample, and on the speed and accuracy of your lab’s identification (ID) and antimicrobial susceptibility testing (AST) systems. Challenges related to limited organism coverage, outdated breakpoints, and inefficient workflows may further disrupt patient care and can lead to delayed results, added tests, and higher costs.
It's time for a more holistic approach to the management of BSI testing.
The BD ID/AST offering, as part of the complete BD BSI solution, helps enable clinicians to make critical patient management decisions based on the speed, accuracy, and breadth of coverage of the BD portfolio.
